当前位置: 首页 > 期刊 > 《中国实用医药》 > 2008年第30期
编号:11702854
蛋白质组学的临床实验与应用(3)
http://www.100md.com 2008年11月5日 《中国实用医药》 2008年第30期
     [10] Hoehn G.T,Suffredini A.F.Proteomics.Crit.Care Med,2005,33(suppl.):444-448.

    [11] Godl K,Wissing J,Kurtenbach A,et al.An efficient proteomics method to identify the cellulartargets of protein kinase inhibitors.Proc.Natl.Acad.Sci,2003,100:15434-15439.

    [12] Brehmer D,Godl K,Zech B,et al.Proteomewide identification of cellular targets affected by bisindolylmaleimidetype protein kinase C inhibitors.Mol.Cell.Proteomics,2004,3:490-500.

    [13] Hu W,Wu W,Yeung S.C,Freedman,et al.Increased expression of heat shock protein70 in adherent ovarian cancer and mesothelioma following treatment with manumycin,a farnesyl transferase inhibitor.Anticancer Res,2002,22:665-672.

    [14] Sjoholt G,Anensen N,Wergeland L,et al.Proteomics in acute myelogenous leukaemia(AML):methodological strategies and identification of protein targets for novel antileukaemic therapy.Curr.Drug Targets,2005,6: 631-646.

    [15] Alessandro R.,Belluco C.,Kohn,E.C.Proteomic approaches in colon cancer:promising tools for new cancer markers and drug target discovery.Clin.Colorectal Cancer,2005,4:396-402., http://www.100md.com(马国中 王继生)
上一页1 2 3